CSIMarket
 
Avadel Pharmaceuticals Plc  (NASDAQ: AVDL)
 

AVDL's Market share relative to its competitors, as of Q3 2025

As of Q3 2025 (Revenue in Millions of $)

Date modified: 2026-05-28T05:41:24+00:00





COMPANY NAME REVENUES
12 Months Ending
Q3 2025
MARKET SHARE
12 Months
Q3 2025
MARKET SHARE
MRQ
Q3 2025
MARKET SHARE
A Quarter Before
Q2 2025
Avadel Pharmaceuticals Plc 248.76 0.55% 0.64 % 0.62 %
Jazz Pharmaceuticals Plc 4,718.13 10.39% 10.20% 11.10%
Amneal Pharmaceuticals Inc 3,196.18 7.04% 7.08% 7.32%
Harmony Biosciences Holdings inc 960.19 2.12% 2.14% 1.97%
Novabridge Biosciences 0.00 0.00% 0.00% 0.00%
Evoke Pharma Inc 14.42 0.03% 0.04% 0.03%
45 more competitors available

Sign in to see all competitors for Avadel Pharmaceuticals Plc.




AVDL's Market share relative to its competitors, as of Q3 2025 within the Major Pharmaceutical Preparations Industry
As of Q3 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2025
MARKET SHARE
12 Months Ending
Q2 2025
MARKET SHARE
MRQ
Q3 2025
MARKET SHARE

Q2 2025
Avadel Pharmaceuticals Plc 0.55% 0.53% 0.64 % 0.62 %
Jazz Pharmaceuticals Plc 10.39% 10.27% 10.20% 11.10%
Amneal Pharmaceuticals Inc 7.04% 7.26% 7.08% 7.32%
Harmony Biosciences Holdings inc 2.12% 2.09% 2.14% 1.97%
Novabridge Biosciences 0.00% 0.00% 0.00% 0.00%
Evoke Pharma Inc 0.03% 0.03% 0.04% 0.03%
43 more companies available

Sign in to see all industry competitors for Avadel Pharmaceuticals Plc.




AVDL's Market share relative to its competitors, as of Q3 2025 within the Healthcare Sector
As of Q3 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2025
MARKET SHARE
12 Months Ending
Q2 2025
MARKET SHARE
MRQ
Q3 2025
MARKET SHARE

Q2 2025
Avadel Pharmaceuticals Plc 0.55% 0.53% 0.64 % 0.62 %
Jazz Pharmaceuticals Plc 10.39% 10.27% 10.20% 11.10%
Amneal Pharmaceuticals Inc 7.04% 7.26% 7.08% 7.32%
Harmony Biosciences Holdings inc 2.12% 2.09% 2.14% 1.97%
Novabridge Biosciences 0.00% 0.00% 0.00% 0.00%
Evoke Pharma Inc 0.03% 0.03% 0.04% 0.03%
45 more companies available

Sign in to see all sector competitors for Avadel Pharmaceuticals Plc.




Note: Market share is calculated based on total revenue. To get a more accurate picture of Avadel Pharmaceuticals Plc's market divisions, geographic dispersion, segments, products, and services, visit Avadel Pharmaceuticals Plc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.